Research progress of T cells in cholangiocarcinoma
Year: 2025
Type: review
Abstract: Cholangiocarcinoma (CCA), a malignant tumor, is typically challenging to detect early and often results in a poor prognosis. In recent years, research interest has grown in the potential application of immunotherapy for CCA treatment. T cells, as a crucial component of the immune system, play a significant role in immune surveillance and therapy for cholangiocarcinoma. This article provides a review of the research advancements concerning T cells in cholangiocarcinoma patients, including their distribution, functional status, and correlation with patient prognosis within the tumor microenvironment. It further discusses the potential applications and challenges of immunotherapy strategies targeting T cells in CCA treatment and anticipates future research directions. A more profound understanding of T cells' role in cholangiocarcinoma can guide the development of clinical treatment strategies, thereby enhancing patient survival rates and quality of life. Finally, we explored the potential risks and side effects of immunotherapy for T-cell cholangiocarcinoma.
Source: Frontiers in Immunology
Authors: Zhiming Wang(Writing – original draft), Yunyan Dai(Writing – original draft), Yunpeng Zhou(Writing – review & editing), Yi Wang(Writing – review & editing), Pinggui Chen(Writing – review & editing), Yaoxuan Li(Writing – review & editing), Yunfei Zhang(Writing – review & editing), Xiaocui Wang(Writing – review & editing), Ying Hu(Writing – review & editing), Haonan Li(Writing – review & editing), Gaopeng Li(Writing – review & editing), Yukai Jing(Writing – review & editing)
Institutions: Shanxi Medical University, Shanxi Academy of Medical Sciences
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Awards: G3206329195, G8523878956
OpenAlex ID: W4407929136
